Overview

Pilot Study to Evaluate ActiMyo Measured Activity in Parkinson Disease Patients & Healthy Volunteers

Status:
Completed
Trial end date:
2017-07-01
Target enrollment:
Participant gender:
Summary
Pre-QuantiPark is a pilot study to evaluate the reliability and responsiveness of ActiMyo measured activity in PD patients. The purpose of the study is to provide validation of the ActiMyo, an innovative home-recording device enabling use in clinical trials and as an innovative tool for PD patient care.
Phase:
N/A
Details
Lead Sponsor:
Institut de Myologie, France
Treatments:
Levodopa